Current-practice guidelines rec- ommend continuation of antiviral therapy until viral replication is undetectable on at least two weekly NAT measurements
If you want to change selection, open document below and click on "Move attachment"
- (no access) - CMV ASM.pdf, p19
|status||not read|| ||reprioritisations|
|last reprioritisation on|| ||suggested re-reading day|
|started reading on|| ||finished reading on|